| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | EAGLE PHARMACEUTICALS INC COM | 1,353,913 | 100,230,000 | 14.10% | ||
| 2 | INSYS THERAPEUTICS INC NEW COM NEW | 3,257,094 | 92,697,000 | 13.04% | ||
| 3 | ABBVIE INC | 1,445,900 | 78,671,000 | 11.07% | ||
| 4 | RETROPHIN INC COM | 3,450,323 | 69,904,000 | 9.84% | ||
| 5 | ORTHOFIX INTERNATIONAL NV | 1,786,535 | 60,296,000 | 8.48% | ||
| 6 | AKORN INC | 1,873,756 | 53,411,000 | 7.51% | ||
| 7 | ANI PHARMACEUTICALS INC COM | 1,056,289 | 41,734,000 | 5.87% | ||
| 8 | OSIRIS THERAPEUTICS INC NEW COM | 2,035,709 | 37,600,000 | 5.29% | ||
| 9 | CARDIOVASCULAR SYS INC DEL COM | 2,326,748 | 36,856,000 | 5.19% | ||
| 10 | PACIFIC BIOSCIENCES CALIF IN | 6,257,861 | 22,904,000 | 3.22% | ||
| 11 | ENANTA PHARMACEUTICALS INC COM | 570,662 | 20,624,000 | 2.90% | ||
| 12 | CATALYST PHARMACEUTICALS INC | 5,802,885 | 17,409,000 | 2.45% | ||
| 13 | VANDA PHARMACEUTICALS INC COM | 1,436,796 | 16,207,000 | 2.28% | ||
| 14 | EPIRUS BIOPHARMA | 2,324,669 | 10,275,000 | 1.45% | ||
| 15 | DERMA SCIENCES INC COM PAR .01 | 1,893,467 | 8,918,000 | 1.25% | ||
| 16 | ADMA BIOLOGICS, INC. | 1,052,142 | 8,796,000 | 1.24% | ||
| 17 | NANOSTRING TECHNOLOGIES INC | 449,325 | 7,189,000 | 1.01% | ||
| 18 | VERICEL CORP | 2,352,940 | 6,376,000 | 0.90% | ||
| 19 | CLOVIS ONCOLOGY INC | 45,183 | 4,155,000 | 0.58% | ||
| 20 | SEASPINE HLDGS CORP COM | 248,502 | 4,026,000 | 0.57% | ||
| 21 | IMPRIVATA INC | 206,448 | 3,669,000 | 0.52% | ||
| 22 | MERUS LABS INTL INC NEW | 1,303,484 | 1,681,000 | 0.24% | ||
| 23 | BIOTIME INC | 539,640 | 1,619,000 | 0.23% | ||
| 24 | VERACYTE INC | 266,794 | 1,251,000 | 0.18% | ||
| 25 | BIOLASE INC | 1,154,372 | 1,039,000 | 0.15% | ||
| 26 | Neothetics Inc | 122,271 | 987,000 | 0.14% | ||
| 27 | AXOGEN INC | 224,400 | 925,000 | 0.13% | ||
| 28 | CTI BIOPHARMA CORP | 460,000 | 672,000 | 0.09% | ||
| 29 | SIENTRA INC | 59,664 | 606,000 | 0.09% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001085146-15-002203, filed 2015.11.09).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
